Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Medulloblastoma in children: a correlation between staging and results of treatment.

× No keyword cloud information.

36 in total

Review 1. Toward a cure for infants with brain tumours: the challenge for the 1990's.

Authors: P M Zeltzer
Journal: Br J Cancer Suppl Date: 1992-08

2. Reirradiation for recurrent cerebral astrocytoma.

Authors: D L Silbergeld; B R Griffin; G A Ojemann
Journal: J Neurooncol Date: 1992-02 Impact factor: 4.130

3. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.

Authors: Thomas E Merchant; Larry E Kun; Matthew J Krasin; Dana Wallace; Murali M Chintagumpala; Shiao Y Woo; David M Ashley; Maree Sexton; Stewart J Kellie; Verity Ahern; Amar Gajjar
Journal: Int J Radiat Oncol Biol Phys Date: 2007-09-24 Impact factor: 7.038

4. MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children.

Authors: J L Ater; J van Eys; S Y Woo; B Moore; D R Copeland; J Bruner
Journal: J Neurooncol Date: 1997-05 Impact factor: 4.130

5. Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma.

Authors: Tomoshige Akino; Xuezhe Han; Hironao Nakayama; Brendan McNeish; David Zurakowski; Akiko Mammoto; Michael Klagsbrun; Edward Smith
Journal: Cancer Res Date: 2014-05-08 Impact factor: 12.701

10. A new staging method versus TNM staging in children with posterior fossa primitive neuroectodermal tumor (medulloblastoma).

Authors: J P Laurent; W R Cheek
Journal: Childs Nerv Syst Date: 1986 Impact factor: 1.475

Medulloblastoma in children: a correlation between staging and results of treatment.

Review 1. Toward a cure for infants with brain tumours: the challenge for the 1990's.

2. Reirradiation for recurrent cerebral astrocytoma.

3. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.

4. MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children.

5. Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma.

6. Medulloblastoma: a critical approach to the management on the basis of 12 years of experience.

7. Intra-arterial BCNU in the treatment of recurrent medulloblastoma.

8. Medulloblastoma in pediatric age: a single-institution review of prognostic factors.

Review 9. Chemotherapy for medulloblastomas and primitive neuroectodermal tumors.

10. A new staging method versus TNM staging in children with posterior fossa primitive neuroectodermal tumor (medulloblastoma).